Header

UZH-Logo

Maintenance Infos

Allergic reactions to the first COVID‐19 vaccine: a potential role of Polyethylene glycol?


Cabanillas, Beatriz; Akdis, Cezmi; Novak, Natalija (2020). Allergic reactions to the first COVID‐19 vaccine: a potential role of Polyethylene glycol? Allergy:Epub ahead of print.

Abstract

The COVID‐19 vaccine developed by Pfizer and BioNTech was approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom (UK) on December 2nd 2020.1 MHRA is therefore the first regulator agency in the world to approve a vaccine to prevent coronavirus disease (COVID‐19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), a virus that is responsible for a global pandemic.

Abstract

The COVID‐19 vaccine developed by Pfizer and BioNTech was approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom (UK) on December 2nd 2020.1 MHRA is therefore the first regulator agency in the world to approve a vaccine to prevent coronavirus disease (COVID‐19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), a virus that is responsible for a global pandemic.

Statistics

Citations

Dimensions.ai Metrics

Altmetrics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > Swiss Institute of Allergy and Asthma Research
Dewey Decimal Classification:610 Medicine & health
Uncontrolled Keywords:Immunology, Immunology and Allergy
Language:English
Date:15 December 2020
Deposited On:11 Jan 2021 10:16
Last Modified:11 Jan 2021 10:16
Publisher:Wiley-Blackwell Publishing, Inc.
ISSN:0105-4538
OA Status:Closed
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1111/all.14711
PubMed ID:33320974

Download

Full text not available from this repository.
View at publisher

Get full-text in a library